{"data":{"id":3196,"citation":"Prime ME, Brookfield FA, Courtney SM, Gaines S, Marston RW, Ichihara O, Li M, Vaidya D, Williams H, Pedret-Dunn A, Reed L, Schaertl S, Toledo-Sherman L, Beconi M, Macdonald D, Mu\u00f1oz-Sanjuan I, Dominguez C, Wityak J.: Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease. ACS Med Chem Lett, Volume 3 (9), 2012","title":"Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.","doi":"10.1021\/ml3001352","doi_url":"https:\/\/doi.org\/10.1021\/ml3001352","pmid":"24900540","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/24900540\/","year":2012,"journal":"ACS Med Chem Lett","volume":"3","issue":"9","page":"731-735","authors":[{"first_name":"Beconi M","last_name":null,"full_name":null},{"first_name":"Brookfield FA","last_name":null,"full_name":null},{"first_name":"Courtney SM","last_name":null,"full_name":null},{"first_name":"Dominguez C","last_name":null,"full_name":null},{"first_name":"Gaines S","last_name":null,"full_name":null},{"first_name":"Ichihara O","last_name":null,"full_name":null},{"first_name":"Li M","last_name":null,"full_name":null},{"first_name":"MacDonald D","last_name":null,"full_name":null},{"first_name":"Marston RW","last_name":null,"full_name":null},{"first_name":"Munoz-Sanjuan I","last_name":null,"full_name":null},{"first_name":"Pedret-Dunn A","last_name":null,"full_name":null},{"first_name":"Prime ME","last_name":null,"full_name":null},{"first_name":"Reed L","last_name":null,"full_name":null},{"first_name":"Schaertl S","last_name":null,"full_name":null},{"first_name":"Toledo-Sherman L","last_name":null,"full_name":null},{"first_name":"Vaidya D","last_name":null,"full_name":null},{"first_name":"Williams H","last_name":null,"full_name":null},{"first_name":"Wityak J.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3196","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3196","created_at":"2024-05-21T09:16:18.000000Z","updated_at":null}}